We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Proteome Sciences Plc | LSE:PRM | London | Ordinary Share | GB0003104196 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.65 | 2.30 | 3.00 | - | 0.00 | 13:55:29 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 5.03M | -2.44M | -0.0083 | -3.19 | 7.82M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/8/2024 23:04 | So, chutes, HOW did they do it? | goatherd | |
22/8/2024 22:40 | Perhaps we will never know, however the manufacturer is outraged that the vessel has sunk The weather was predicted, plenty knew the yacht intimately, one worked as a rigger during construction and was now a diver The first sniff of anything suspicious, and you can put 2+2 = A 12 yr fraud trial, billions of dollars, an American behemoth, a jogger run down only days before. They certainly didn't miss the ones they wanted. | chutes01 | |
22/8/2024 19:17 | I can't see it Chutes. I'm with Richard on this. | canaletto | |
22/8/2024 14:12 | It's all possible where the US and $Billions are involved Anticipate the weather, divers move in ahead to open hatches Always collateral damage, MS/Lawyer in for free. Too much to the naked eye. | chutes01 | |
22/8/2024 13:33 | Yes, Chutes, I do agree. BUT how on earth could it have been done? The cyclone was unpredicted, and possibly unpredictable. and the hull is apparently totally undamaged. The boat had the tallest aluminium mast in the World, and the storm could have exerted enough force to lay the boat on its side. It was hot, so the hatches would have been open. So, once on its side, the inexhaustable sea would have poured in. Interesting though conspiracy theories are, I don't see how it could have been done. The co-defendant - run down by a car, Yes, sure, it could have been deliberate. | goatherd | |
22/8/2024 13:07 | Was it a brutal act of nature Too many billions involved at Autonomy and co-defendant mowed down a few days earlier DYOR. | chutes01 | |
22/8/2024 13:06 | Many have jumped on the bandwagon with the single biomarker p-tau217, but it is quite limited in its use. An accurate AD diagnostic / prognostic will involve a multi-biomarker solution, which is exactly what PRM's granted & pending AD biomarkers patents provide. Watch this space closely, I believe Proteome Sciences AD biomarkers (as they suggest) will be critical moving forward. | pools2 | |
22/8/2024 13:01 | Colinhy, (re 9305) Yes, I take your point. But would you say the same about Stroke? | goatherd | |
22/8/2024 11:26 | I thought most posters had fully recognised that this was a busted flush well over a decade ago. | barry evans | |
22/8/2024 11:12 | Goetherd re your post #93009 Many companies have already produced highly accurate tests which Proteome Sciences has already acknowledged do not fall within the scope their IP this is because the methodology those companies use require only one or two of the markers identified in Proteome Sciences IP. It seems to me that there will be little scope for PRM to commercialise its Alzheimer's IP which has multiple marker methodology because a growing number of simpler one or two marker tests are already coming to the market. It difficult to see how Proteome Sciences IP is critical to the development of novel diagnostic tests for Alzheimer’s disease as stated the Proteome Sciences Final Fesults for 2023. as many companies have already produced Alzheimer’s tests without falling within the scope of PRM IP. | colinhy | |
22/8/2024 11:05 | Oh aye, of course you did. Anyone that can remember your behaviour around that time knows precisely what stance you had. Dear me. | barry evans | |
22/8/2024 10:59 | Actually it is by no means the first time! I first got cross when a city presentation in about 2002 named 12 projects that would come off within 12 months. How many did? You probably got that right - none. | goatherd | |
22/8/2024 08:12 | Hyperplexing TMTpro 96 plex assays now possible. | pools2 | |
22/8/2024 08:04 | First time I've seen you crack a little displeasure after all these years re PRM,there is hope for you yet Richard. | peverill | |
22/8/2024 04:31 | These big city players can get around most things (hence CJ's nickname slippery).....apart from brutal acts of nature as demonstrated recently. | canaletto | |
21/8/2024 17:58 | I think the plan, or rather belief, at inception was that the discovery of a single biomarker for a disease would give a positive, unique, diagnosis for that disease. Unfortunately we all now know that was simply not so. "We all" there included most, probably all, of Proteome's management and scientists. Sadly we are now in a position where we have to wait, and hope someone, somewhere, infringes our, numerous, patents. And then get royalties. The royalties could be very substantial indeed. Alzheimer's probably biggest, then stroke. We simply have not got the funds to do the work ourselves; though I do think we have, or can get, sufficient funds to legally pursue infringment. That is why I still hold. That, and hope! | goatherd | |
21/8/2024 17:42 | Let's hope it doesn't take another 30 for something/anything to happen.I don't think this was the plan at inception. | peverill | |
21/8/2024 17:04 | Oh have some patience for goodness sake peverill - if has only been 30 years, give or take. Rome wasn’t built in a day. Apparently. | monte1 | |
16/8/2024 09:49 | Has there ever been.!! | peverill | |
16/8/2024 09:11 | I note Thermo already have a Monkeypox DNA test kit on the market, nothing doing there then | elpirata | |
12/8/2024 10:43 | Weedol STRONG BUY | elpirata |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions